Penticton Herald

Side effects of hydroxyure­a

- KEITH ROACH

DEAR DR. ROACH: Recently, I was diagnosed with essential thrombocyt­hemia. The recommende­d treatment is the drug hydroxyure­a because I turned 60 this past year and have a mutation in the JAK 2 gene.

If I had not turned 60, the recommende­d treatment would be aspirin alone. Currently, I am taking the recommende­d 81-mg aspirin dose daily. I have a very healthy lifestyle: I’m an avid runner, with workouts twice a week at the gym, and I have no history of blood clots, etc. I have no symptoms at this time. I’ve been getting monthly blood draws to monitor my platelet counts. They are climbing; my last was 659.

Looking at the possible side effects of hydroxyure­a, I am hesitant to start that course of treatment just because I am over 60. What is your opinion of my waitand-see attitude? -- B.T.

ANSWER: Essential thrombocyt­hemia is a myeloproli­ferative neoplasm, a case of the body making too many white or red blood cells or platelets. Whether it’s a blood cancer or not is debatable. It has some characteri­stics that are cancer-like, but the main concerns with ET are blood clotting, paradoxica­l bleeding and symptoms. It can rarely transform to acute myeloid leukemia, and there is no treatment to prevent the transforma­tion.

Since you have no symptoms, the main risks to you are abnormal blood clotting and bleeding. Your clotting risk is considered intermedia­te, because of the JAK2 mutation and your being over age 60. In one study, that was associated with a clot risk of about 3.6 percent per year.

In another study — of some patients similar to you and others with a history of clotting — 24 percent of people on aspirin alone had a clot in 27 months, whereas among those taking aspirin and hydroxyure­a, only 3.6 percent had a clot. Because you have no history of clotting, the benefit for you from the hydroxyure­a will likely be smaller than that seen in this study, but still pretty significan­t. Bleeding may occur because the platelets, although numerous, are not normal. About 5 percent of people with ET will have a serious bleeding event.

Dr. Keith Roach is a Florida-based physician.

 ??  ??

Newspapers in English

Newspapers from Canada